© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Sherri Tenpenny & Steve Quayle on The Hagmann Report (Full show)
247 views • 04/14/2021
Hagmann Report, April 8, 2021
SPECIAL REPORT: Steve Quayle and Dr. Sherri Tenpenny join Doug Hagmann to discuss the CCP Virus “vaccines,” or more correctly described as an experimental genetically modified tool. This is a “must listen” episode! Please share this episode with your friends and family.
https://www.hagmannreport.com/special-report-dr-sherri-tenpenny-steve-quayle-20210408/
Hagmann Report
Website: https://www.hagmannreport.com/
Rumble: https://rumble.com/HagmannReport
Brighteon: https://www.brighteon.com/channels/douglash59
Steve Quayle’s website https://www.stevequayle.com/
Dr. Sherri Tenpenny’s website – https://www.drtenpenny.com/
SPECIAL REPORT: Steve Quayle and Dr. Sherri Tenpenny join Doug Hagmann to discuss the CCP Virus “vaccines,” or more correctly described as an experimental genetically modified tool. This is a “must listen” episode! Please share this episode with your friends and family.
https://www.hagmannreport.com/special-report-dr-sherri-tenpenny-steve-quayle-20210408/
Hagmann Report
Website: https://www.hagmannreport.com/
Rumble: https://rumble.com/HagmannReport
Brighteon: https://www.brighteon.com/channels/douglash59
Steve Quayle’s website https://www.stevequayle.com/
Dr. Sherri Tenpenny’s website – https://www.drtenpenny.com/
Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.
10 videos • 11:15:21 • Public
